Literature DB >> 14768708

Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. X. Immunoselection of tumor variants differing in tumor antigen expression and metastatic capacity.

V Schirrmacher1, K Bosslet.   

Abstract

We previously described morphological, functional and antigenic differences between a chemically-induced DBA/2 lymphoma, Eb, and a spontaneous variant, ESb, which arose in 1968 and had highly increased metastatic capacity. Now we present evidence that the two cell lines, in spite of the differences observed, are still related. (1) Shifts from Eb to ESb can be reproduced after 11 years. They occur during routine i.p. transplantation, especially when high cell numbers are passaged. (2) ESb variant cells can be recovered from Eb tumor populations after immunoselection in vivo with specific anti-Eb cytolytic T lymphocytes (CTL). (3) Parental-type Eb cells can be isolated from ESb tumor populations after immunoselection in vitro with specific anti-ESb CTL Ten ESb cells mixed with 10(6) Eb cells and inoculated s.c. caused a shift in the mortality curve suggesting that a possible contamination of the Eb population with pre-existing ESb variant cells was less than 1 in 100,000.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 14768708     DOI: 10.1002/ijc.2910250614

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

1.  Cell surface energy and membrane associated actin in lymphocytes.

Authors:  B Mely-Goubert; D Bellgrau; D F Gerson
Journal:  Cell Biophys       Date:  1988-08

2.  The inflammatory reaction and malignant tumour development one may be bested by the other: ancient concepts and recent evidence.

Authors:  K W Stahl; G Mathé
Journal:  Agents Actions       Date:  1984-02

3.  Immunoselection of tumor variants resistant to antibody-mediated cytotoxicity. Their immunologic and metastatic characterization.

Authors:  J R Starkey; W C Davis; J E Talmadge
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

4.  Antigenic variation in cancer metastasis: immune escape versus immune control.

Authors:  V Schirrmacher; M Fogel; E Russmann; K Bosslet; P Altevogt; L Beck
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

5.  Clonal analysis of expression of tumor-associated transplantation antigens and of metastatic capacity.

Authors:  V Schirrmacher; K Bosslet
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

6.  Tissue inhibitor of metalloproteinases (TIMP)-1 creates a premetastatic niche in the liver through SDF-1/CXCR4-dependent neutrophil recruitment in mice.

Authors:  Bastian Seubert; Barbara Grünwald; Julia Kobuch; Haissi Cui; Florian Schelter; Susanne Schaten; Jens T Siveke; Ngee H Lim; Hideaki Nagase; Nicole Simonavicius; Mathias Heikenwalder; Thomas Reinheckel; Jonathan P Sleeman; Klaus-Peter Janssen; Percy A Knolle; Achim Krüger
Journal:  Hepatology       Date:  2014-11-24       Impact factor: 17.425

7.  Interaction of high or low metastatic related tumor lines with normal or lymphokine-activated syngeneic peritoneal macrophages: in vitro analysis of tumor cell binding and cytostasis.

Authors:  V Schirrmacher; B Appelhans
Journal:  Clin Exp Metastasis       Date:  1985 Jan-Mar       Impact factor: 5.150

8.  The selective nature of metastasis.

Authors:  J E Talmadge
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

Review 9.  Tumor progression in metastasis: an experimental approach using lectin resistant tumor variants.

Authors:  R S Kerbel; J W Dennis; A E Largarde; P Frost
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

Review 10.  Premetastatic niche formation in the liver: emerging mechanisms and mouse models.

Authors:  Achim Krüger
Journal:  J Mol Med (Berl)       Date:  2015-09-24       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.